Cita APA (7a ed.)

T, Z., P, Z., & HX, L. (2021). CAFs-Derived Exosomal miRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging. Dove Medical Press.

Cita Chicago Style (17a ed.)

T, Zhang, Zhang P, y Li HX. CAFs-Derived Exosomal MiRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging. Dove Medical Press, 2021.

Cita MLA (8a ed.)

T, Zhang, et al. CAFs-Derived Exosomal MiRNA-130a Confers Cisplatin Resistance of NSCLC Cells Through PUM2-Dependent Packaging. Dove Medical Press, 2021.